Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Region Trims More from Budget
Cold Weather Policy for Homeless Not Changing
Niagara Falls Handling Salt Shortage
Man Killed in Tent Fire
Region Updated on Measles Outbreak
St. Catharines Draws X Through X
Police Looking for Laundry Thief
Toronto Man Charged with Trafficking